Td Waterhouse Canada Inc. Qualigen Therapeutics, Inc. Transaction History

Td Waterhouse Canada Inc.

  • $14.8 Trillion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 13, 2023
SELL
$0.28 - $2.92 $2 - $23
-8 Closed
0 $0
Q4 2021

Nov 13, 2023
BUY
$0.94 - $2.56 $7 - $20
8 New
8 $9,000

About Qualigen Therapeutics, Inc.

QLGN Quotes by TradingView
  • Ticker QLGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,795,500
  • Market Cap $6.6M
  • Description
  • Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate ...
More about QLGN
Track This Portfolio

Track Td Waterhouse Canada Inc. Portfolio

Follow Td Waterhouse Canada Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Waterhouse Canada Inc., based on Form 13F filings with the SEC.

News

Stay updated on Td Waterhouse Canada Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email